Last reviewed · How we verify
NCT03807648
I USE LR in the ED
trial testing Data Inclusion in Kidney Injury in 200,000 participants. Completed in 31 January 2020.
31 December 2019
Quick facts
| Lead sponsor | Intermountain Health Care, Inc. |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 200,000 |
| Start date | 20 December 2018 |
| Primary completion | 31 December 2019 |
| Estimated completion | 31 January 2020 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Data Inclusion
Conditions studied
- Kidney Injury — all drugs for Kidney Injury →
Sponsor
Intermountain Health Care, Inc. — full company profile →
Who can join
18 and older, any sex, with Kidney Injury. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To study the difference in mortality and major adverse kidney events during and after treatment in the emergency department with intravenous fluids per standard of care at 30 days before and after the system-wide implementation.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03807648
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Kidney Injury
Currently open trials in the same condition.
- NCT06585722 — Association Between Venous Excess Ultrasound Grading System and Acute Kidney Injury in the ICU Population · recruiting
- NCT05696444 — Medtronic Hugo™ Robotic Assisted Surgery (RAS) System in Urologic Surgery (Expand URO) · NA · active not recruiting
- NCT06781476 — Evaluation of Urinary Biomarkers Trend in Preterm Very Low Birth Weight Infants · recruiting
- NCT05283512 — Intravenous vs. Oral Hydration to Reduce the Risk of Post-Contrast Acute Kidney Injury After Intravenous Contrast-Enhanc · NA · recruiting
- NCT04902846 — Immune Checkpoint Inhibitors Nephrotoxicity · recruiting
Other Intermountain Health Care, Inc. trials
Trials by the same sponsor.
- NCT07334795 — Intermountain Stewardship in Community Outpatient Settings-Resources & Engagement-Pediatrics · active not recruiting
- NCT07348289 — PIVO Use for Blood Cultures in the Emergency Department · recruiting
- NCT06865781 — Vital Signs Reduction Study · NA · active not recruiting
- NCT05936021 — Clinical Validation Study for Optimization of Anemia MAnagement in Hemodialysis Patients With End Stage Kidney Disease U · NA · unknown
- NCT05141396 — Telehealth-Enabled, Real-time Audit and Feedback for Clinician AdHerence (TEACH) · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03807648 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Intermountain Health Care, Inc.
- Last refreshed: 12 February 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03807648.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing